| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.004 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |